Meeting
2023 ASCO Quality Care Symposium
First-line maintenance use among patients with advanced ovarian cancer in a community oncology setting: A retrospective observational study in the United States (US).
Authors
Dana Meredith Chase
University of California, Los Angeles, Los Angeles, CA
Dana Meredith Chase, Laura Iadeluca, Jonathan Lim, Wan-Yu Tseng, Purva Bulsara, Karen Todoroff, Gregory Patton
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Real-World Evidence
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 544)
DOI
10.1200/OP.2023.19.11_suppl.544
Abstract #
544
Poster Bd #
L19
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Reasons for first-line maintenance therapy discontinuation among patients with newly diagnosed advanced ovarian cancer treated in real-world settings.
First Author: Jinan Liu
Poster
2023 ASCO Annual Meeting
Effectiveness of PARP inhibitor maintenance therapy (mPARPi) in advanced ovarian cancer (OC) by BRCA1/2 and HRD signature in real-world practice.
First Author: Debra L. Richardson
Poster
2022 ASCO Annual Meeting
Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).
First Author: Jean Emmanuel Kurtz
Poster
2021 ASCO Quality Care Symposium
Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?
First Author: Jinan Liu